Marker Therapeutics MRKR
NASDAQ MRKR
$1.07 -0.06 (-5.31%)
At close: Oct 22, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Construction in Progress (2020 - 2022)

Updated

Marker Therapeutics (MRKR) recorded Construction in Progress of $4.09 million in Q1 2022, up 83.7% from the prior quarter.

Analysis

Marker Therapeutics (MRKR) Construction in Progress (2020 - 2022) Analysis & Trends

At the end of FY2021, Marker Therapeutics reported Construction in Progress of $2.23 million, down 67.2% from FY2020.

  • Across earlier years, Construction in Progress came in at $6.79 million in FY2020.
  • The Q1 2022 figure is the highest quarterly Construction in Progress since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Marker Therapeutics 20.86 Mn -39.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 4.09 Mn
Dec 31, 2021 2.23 Mn
Sep 30, 2021 600,005.00
Dec 31, 2020 6.79 Mn
Sep 30, 2020 4.60 Mn
Jun 30, 2020 2.63 Mn
API Access

Marker Therapeutics Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=MRKR&period=max&api_key=YOUR_API_KEY